|
|
Influence of Ligustrazine Hydrochloride Injection combined with Ureklin on hemorheology and thromboelastogram in patients with acute cerebral infarction |
KE Laishun1 LIU Huabin1 TU Yanfen |
1. Department of Neurology, Zhangzhou Third Hospital, Fujian Province, Zhangzhou 363000, China;
2. Department of Brain Disease, Zhangzhou Hospital of Traditional Chinese Medicine, Fujian Province, Zhangzhou 363000, China |
|
|
Abstract Objective To investigate the influence of Ligustrazine Hydrochloride Injection combined with Urecolin on hemorheology and thromboelastogram in patients with acute cerebral infarction. Methods A total of 96 patients with acute cerebral infarction treated in Zhangzhou Third Hospital from January to December 2020 were selected as the research objects. They were divided into the control group (48 cases) and the observation group (48 cases) according to random number table method. The control group was treated with Urecolin single drug therapy, and the observation group was treated with Ligustrazine Hydrochloride Injection combined with Urecolin therapy. The total effective rate,hemorheological indexes and thromboelastogram indexes of the two groups were compared. Results The total effective rate of the observation group was higher than that of the control group, the difference was statistically significant (P<0.05). The four indexes of high shear whole blood viscosity, plasma viscosity, fibrinogen and low shear whole blood viscosity in the observation group were lower than those in the control group, the differences were statistically significant(P<0.05). The coagulation reaction time of the observation group was shorter than that of the control group, the formation time of blood cell agglutination block of the observation group was longer than that of the control group, the formation rate of blood cell agglutination block of the observation group was lower than that of the control group, and the maximum blood clot intensity of the observation group was shorter than that of the control group, the differences were statistically significant (P<0.05). Conclusion In the clinical treatment of patients with acute cerebral infarction, Ligustrazine Hydrochloride Injection combined with Ureklin has a good effect. After its implementation, the total effective rate is higher, and it can more effectively improve the hemorheology and thromboelastogram indexes of patients. It has more advantages and is worthy to be popularized in clinical application.
|
|
|
|
|
[4] |
陈杰,柳学勇.尤瑞克林联合rt-PA 静脉溶栓治疗对急性脑梗死患者的影响[J].实用中西医结合临床,2021,21(13):52-53.
|
[5] |
张卫星.注射用尤瑞克林治疗急性脑梗死患者的效果[J].中国民康医学,2021,33(3):21-23.
|
[6] |
艾仕荟,李欣.尤瑞克林治疗急性脑梗死的药理分析及对神经功能的影响[J].广东化工,2021,48(6):33,34.
|
[7] |
邱伟东.老年急性脑梗死患者应用尤瑞克林治疗的效果分析及血清CRP、尿酸和血液流变学的影响[J].世界最新医学信息文摘,2021,21(51):169-170.
|
[8] |
李超,杨子贤,罗太敏,等.奥扎格雷钠注射液治疗急性血栓性脑梗死的快速卫生技术评估[J].中国医院用药评价与分析,2020,20(7):836-839,844.
|
[1] |
李邦林.尤瑞克林对急性脑梗死患者血清炎性因子水平的影响[J].现代医学与健康研究(电子版),2021,5(11):8-10.
|
[2] |
曹江红,徐余田.尤瑞克林对急性脑梗死术后血清炎性因子及血液流变学的影响分析[J].糖尿病天地,2021,18(10):61.
|
[3] |
王茜,周辰珩.强化药物方案对急性分水岭脑梗死患者凝血功能指标及预后的影响[J].中国医刊,2021,56(8):916-919.
|
[9] |
Chen NY,Guo M,Yu D,et al.Bioinformatics study of plasma differentially expressed proteins in H-type hypertension with or without acute cerebral infarction[J].J Behav Brain Sci,2021,11(1):1-9.
|
[10] |
Zhang H,Li CL,Wan F,et al.Efficacy of cattle encephalon glycoside and ignotin in patients with acute cerebral infarction:a randomized,double-blind,parallel-group,placebo-controlled study[J].Neural Regen Res,2020,15(7):1266-1273.
|
[11] |
吴昊.醒脑静联合尤瑞克林对急性脑梗死患者的临床疗效[J].河南医学研究,2020,29(5):845-846.
|
[12] |
尤晓涵,杨淼,明霞光,等.盐酸川芎嗪注射液联合丁苯酞软胶囊治疗急性脑梗死疗效及对患者血液流变学影响[J].陕西中医,2020,41(6):743-745,757.
|
[13] |
祁景,刘小军,祁邵艳,等.盐酸川芎嗪联合奥扎格雷对急性脑梗死患者神经功能缺损和血液流变学的影响[J].世界中西医结合杂志,2020,15(4):710-713.
|
[14] |
曲明.依达拉奉联合尤瑞克林治疗急性脑梗死的临床分析[J].中国冶金工业医学杂志,2020,37(1):17-18.
|
[15] |
Kong DS,Chen LP,Huang WF,et al.Combined therapy with ligustrazine and paeonol mitigates hepatic fibrosis through destroying mitochondrial integrity of stellate cell[J].Am J Transl Res,2020,12(4):1255-1266.
|
|
|
|